Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Revenue (Tables)

Note 7 - Revenue (Tables)

9 Months Ended

Sep. 30, 2023

Notes Tables

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

		*September 30, 2023*				*December 31, 2022*
Deferred extended maintenance and support		$	3,619				2,124
Customer advances			80				29
Total deferred revenues			3,699				2,153
Less current portion			(1,635	)			(1,121	)
Deferred revenues, non-current		$	2,064			$	1,032

Beginning balance		$	2,153
Deferral of revenue			3,506
Recognition of deferred revenue			(1,960	)
Ending balance		$	3,699

Disaggregation of Revenue [Table Text Block]

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	3,390			$	190			$	3,580
Service and support			726				—				726
Subscriptions			245				—				245
Parts and other			27				29				56
		$	4,388			$	219			$	4,607

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	10,041			$	308			$	10,349
Service and support			2,092				—				2,092
Subscriptions			781				—				781
Parts and other			158				52				210
		$	13,072			$	360			$	13,432

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	2,338			$	72			$	2,410
Service and support			484				—				484
Subscriptions			237				—				237
Parts and other			165				33				198
		$	3,224			$	105			$	3,329

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	5,670			$	544			$	6,214
Service and support			1,440				—				1,440
Subscriptions			678				—				678
Parts and other			438				484				922
Collaborative arrangements			107				—				107
		$	8,333			$	1,028			$	9,361